Hondramine tablets, derived from bovine cartilage, offer a unique blend of proteins and nucleoproteins that selectively target cartilage cells. This targeted action normalizes metabolic processes within chondrocytes, reducing the risk of various joint disorders. Clinical trials involving 120 patients with osteoarthritis of the knee, spinal osteochondrosis, and systemic osteoporosis demonstrated Hondramine's effectiveness. Assessment focused on subjective symptom improvement, objective laboratory and instrumental findings, and musculoskeletal function. Results consistently showed significant pain reduction and increased range of motion in affected joints. Hondramine significantly alleviated even chronic, treatment-resistant symptoms. While the clinical effect varied slightly depending on disease stage (less pronounced in older patients), the subjective experience was overwhelmingly positive.
Hondramine is a dietary supplement providing a source of polypeptides and nucleic acids, beneficial for:
Adults: 1-3 tablets 2-3 times daily, 10-15 minutes before meals, with water. Do not chew. Treatment course: 30-45 days.
Individual intolerance to product components, pregnancy, breastfeeding.
Hondramine, joint pain, osteoarthritis, osteochondrosis, osteoporosis, cartilage, joint health, dietary supplement, pain relief, range of motion, bovine cartilage, polypeptides, nucleic acids, arthritides, connective tissue diseases, post-surgery recovery, sports injuries, musculoskeletal disorders, chondrocytes, supplement, tablets, 155mg, 40 tablets, 3 packs.
US: temporary delays — postal services aligning new import rules, 
EU: 1–2 weeks, 🌍 Worldwide: 1–4 weeks ✈️